Tinkerine_Teaser

All About 3D Printing Company Tinkerine

3D printing stocks have been on a bit of a slump lately. The Materialise (NASDAQ:MTLS) IPO this week is trading at almost the exact same price the shares were issued at, showing that investors are becoming somewhat immune to the hype surrounding this space. As of this month, one other 3D printing company that U.S. investors can now trade is Tinkerine.     About Founded in May of 2012, Tinkerine (CVE:TTD) sells consumer 3D printers along with software and consumables. The Company completed a reverse takeover transaction with White Bear Resources earlier this year and began trading on the Canadian Venture Exchange. They also began trading in the US market this month (OTCMKTS:TKSTF). In April of 2014, Tinkerine completed a share transaction at around 23 cents per share for proceeds of around $2.8 million. Of this amount, they currently have $2.5 million in cash on hand to fund their business [...]

Solexel_Teaser

Solexel Grows Cheap Solar Cells Using Silicon Gas

Solar ETFs have been on a tear since the beginning of 2013 with the Guggenheim Solar ETF (NYSEARCA:TAN) having returned over +120% to date. However investors who would have bought and held this same ETF when it debuted in April of 2008 to the present day would have paper losses of -84%, even with the benefits of diversification that ETFs offer. Venture capitalists are even more gun shy with private companies such as Konarka, the solar cell manufacturer which was co-founded by a Nobel laureate and took in $200 million from the likes of Total, Chevron, and Draper Fisher Jurvetson, having declared bankruptcy in 2012 with almost no salvageable value. One private solar cell manufacturer with strong backing and a follow on round of funding announced just today is Solexel.       About Founded in 2007, Milpitas, California based Solexel has developed a unique process to manufacture high [...]

NANTHEALTH_Teaser

Will NANTHEALTH Revolutionize the U.S. Healthcare System?

In evaluating the merits of a company, one promising indication of future success is to look at the pedigree of the company's leadership. This is where most over-the-counter stocks fail miserably, and this is also wear success can beget further success for tenured executives who have proven their talents for creating value. One man, Patrick Soon-Shiong, has done just this and made himself the wealthiest American in the healthcare industry having amassed a fortune of $7.2 billion. Soon-Shiong invented the first FDA approved nanoparticle delivery technology for the treatment of breast cancer, Abraxane, which is now approved in over 40 countries. The company he founded to develop and maufacture Abraxane, Abraxis Biosciences, was sold to Celgene for around $3 billion in 2010. Prior to that, Soon-Shiong founded and sold American Pharma Partners (APP) to Fresenius, a German dialysis company, for $5.6 billion, of which [...]

FEIC_Teaser

FEIC: Supplying the Picks and Shovels for Nanotechnology

In the 1850s during the time of the gold rush, one businessman realized he could make the same amount of money from the gold boom with far less risk by selling essentials to the miners as opposed to engaging in the risky practice of gold mining like others. Levi Strauss was his name, and went on to amass a fortune of about $163 million in today's money with his world-renound blue jeans company remaining in business still today. About 10 years ago when nanotechnology was becoming hyped throughout the investment community as the next greatest thing, one company that was often mentioned by pundits as supplying the "picks and shovels" to the development of nanotechnology was FEI Corporation (NASDAQ:FEIC). While most of the companies in the now discontinued Merrill Lynch Nanotechnology Index couldn't even manage to beat the S&P 500 returns over the past ten years, FEI was one of the four companies that [...]

FEIC_Teaser

FEIC: Supplying the Picks and Shovels for Nanotechnology

In the 1850s during the time of the gold rush, one businessman realized he could make the same amount of money from the gold boom with far less risk by selling essentials to the miners as opposed to engaging in the risky practice of gold mining like others. Levi Strauss was his name, and went on to amass a fortune of about $163 million in today's money with his world-renound blue jeans company remaining in business still today. About 10 years ago when nanotechnology was becoming hyped throughout the investment community as the next greatest thing, one company that was often mentioned by pundits as supplying the "picks and shovels" to the development of nanotechnology was FEI Corporation (NASDAQ:FEIC). While most of the companies in the now discontinued Merrill Lynch Nanotechnology Index couldn't even manage to beat the S&P 500 returns over the past ten years, FEI was one of the four companies that [...]

Lastest Articles

SunShare_Teaser

SunShare and “Community Solar Gardens”

Rooftop solar sounds like a great idea. You can have solar panels installed on your roof for no money up front and can not only power your house but also can potentially sell some of the electricity you generate back to the grid. But what if you don't have a suitable rooftop [...]

3D_Printing_Teaser

Nanotechnology Investing and Large Cap Companies

In a recent article, we highlighted the fact that the now discontinued Merrill Lynch Nanotechnology Index did not show investors superior returns when compared to the returns of the S&P 500 over the past ten years. This means that "nanotechnology investors" would have [...]

mCube_Teaser

mCube Looks to Disrupt the MEMS Industry

Micro Electro Mechanical Systems or MEMS may not be something you've heard about but they are something you use every day if you have a smartphone. A MEMS device will typically consist of a microprocessor and any number of components that interact with the surroundings such [...]

Tinkerine_Teaser

All About 3D Printing Company Tinkerine

3D printing stocks have been on a bit of a slump lately. The Materialise (NASDAQ:MTLS) IPO this week is trading at almost the exact same price the shares were issued at, showing that investors are becoming somewhat immune to the hype surrounding this space. As of this month, [...]